Axim Biotechnologies, Inc. SEC filings AXIM
Axim Biotechnologies, Inc. has 306 filings in SEC EDGAR's recent list, going back to Mar 10, 2011. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2024, covering the quarter ended Jun 30, 2024. The most recent current report (Form 8-K) was filed on Oct 15, 2024 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 15, 2024 | Jan 30, 2024 |
| 4/A | Primary document | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 3 | Initial insider ownership | May 30, 2023 | May 23, 2023 |
| 144 | Notice of proposed sale | Oct 7, 2022 | — |
| 4 | Insider transaction | Sep 23, 2022 | Sep 23, 2022 |
| 3 | Initial insider ownership | Sep 23, 2022 | Sep 23, 2022 |
| 4 | Insider transaction | Sep 23, 2022 | Sep 23, 2022 |
| 4 | Insider transaction | Sep 23, 2022 | Dec 10, 2020 |
| 4 | Insider transaction | Sep 23, 2022 | Sep 23, 2022 |
| 4 | Insider transaction | Sep 23, 2022 | May 13, 2020 |
| 4 | Insider transaction | Sep 23, 2022 | Sep 23, 2022 |
| 4 | Insider transaction | Sep 23, 2022 | May 13, 2020 |
| 4 | Insider transaction | Sep 23, 2022 | Sep 23, 2022 |
| 4 | Insider transaction | Sep 23, 2022 | May 6, 2021 |
| 4 | Insider transaction | Sep 23, 2022 | Dec 10, 2020 |
| 4 | Insider transaction | Sep 23, 2022 | Mar 19, 2020 |
| 4 | Insider transaction | Sep 23, 2022 | Jan 2, 2019 |
| SC 13D | Ownership over 5% (active) | Sep 23, 2022 | — |
| 3 | Initial insider ownership | Sep 23, 2022 | Feb 20, 2019 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 31, 2022 | — |
| 4 | Insider transaction | Aug 31, 2022 | Aug 29, 2022 |
| SC 13D | Ownership over 5% (active) | Aug 31, 2022 | — |
| 3 | Initial insider ownership | Aug 31, 2022 | Mar 19, 2020 |
| SC 13D | Ownership over 5% (active) | Aug 31, 2022 | — |
| 3 | Initial insider ownership | Aug 31, 2022 | Mar 19, 2020 |
| 4 | Insider transaction | Aug 26, 2022 | Aug 22, 2022 |
| 4 | Insider transaction | Feb 15, 2022 | Feb 10, 2022 |
| 4 | Insider transaction | Apr 6, 2018 | Mar 21, 2018 |
| 3 | Initial insider ownership | Jun 23, 2017 | May 18, 2017 |
| 3 | Initial insider ownership | Jun 23, 2017 | May 18, 2017 |
| 3 | Initial insider ownership | Jun 23, 2017 | Jun 29, 2016 |
| 3 | Initial insider ownership | Jun 23, 2017 | May 18, 2017 |
| 3 | Initial insider ownership | Jun 23, 2017 | May 18, 2017 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 1, 2017 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 1, 2017 | — |
| 5/A | Primary document | Feb 28, 2017 | Dec 31, 2016 |
| 5 | Annual insider ownership | Feb 15, 2017 | Dec 31, 2016 |
| 5 | Annual insider ownership | Feb 15, 2017 | Dec 31, 2016 |
| 5 | Annual insider ownership | Feb 15, 2017 | Dec 31, 2016 |
| 4 | Insider transaction | Feb 5, 2016 | Feb 5, 2016 |
| 4 | Insider transaction | Dec 30, 2015 | Apr 23, 2015 |
| 4 | Insider transaction | Dec 30, 2015 | Apr 23, 2015 |
| 4 | Insider transaction | Mar 3, 2015 | Feb 23, 2015 |
| 4 | Insider transaction | Apr 30, 2014 | Mar 21, 2014 |
| SC 13D | Ownership over 5% (active) | Apr 28, 2014 | — |
| 3 | Initial insider ownership | Apr 25, 2014 | Mar 21, 2014 |
| 3 | Initial insider ownership | Apr 25, 2014 | Mar 21, 2014 |
| 3 | Initial insider ownership | Apr 25, 2014 | Mar 21, 2014 |
| 3 | Initial insider ownership | Apr 25, 2014 | Mar 20, 2014 |
| 3 | Initial insider ownership | Apr 25, 2014 | Mar 21, 2014 |
| SC 13D | Ownership over 5% (active) | Apr 25, 2014 | — |
| 5 | Annual insider ownership | Jan 28, 2014 | Dec 31, 2013 |
| 5 | Annual insider ownership | Jan 18, 2013 | Dec 31, 2012 |
| 5 | Annual insider ownership | Jan 5, 2012 | Dec 31, 2011 |
| 3 | Initial insider ownership | Jul 13, 2011 | Jul 12, 2011 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXIM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514946
- Former names
- AXIM INTERNATIONAL INC. (until Aug 13, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.